Communiqués Active Biotech AB London S.E.

Actions

Temps réel estimé Cboe Europe 11:35:38 01/10/2026			Varia. 5j.	Varia. 1 janv.
3,895 ^SEK	-39,62%		+18,15%	+41,78%

30/09	Active Biotech obtient un brevet japonais pour le laquinimod	FW
30/09	Active Biotech obtient un brevet pour le laquinimod au Japon	FW

30/09	Active Biotech Strengthens Global Patent Protection for Laquinimod with Patent Grant in Japan	AQ
20/08	Active Biotech (Q2 Review): Record-Deals in Myelofibrosis in 2026	AQ
20/08	Active Biotech Interim Report Q2 2026	AQ
18/08	Active Biotech expands US collaboration to advance tasquinimod clinical development in myelofibrosis	AQ
24/07	First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis	AQ
30/06	Number of shares and votes in Active Biotech	AQ